245 related articles for article (PubMed ID: 21083339)
21. Sensitive determination of a drug candidate in dried blood spots using a TLC-MS interface integrated into a column-switching LC-MS/MS system.
Heinig K; Wirz T; Gajate-Perez A
Bioanalysis; 2010 Nov; 2(11):1873-82. PubMed ID: 21083495
[TBL] [Abstract][Full Text] [Related]
22. Assessment of DBS technology for the detection of therapeutic antibodies.
Prince PJ; Matsuda KC; Retter M; Scott G
Bioanalysis; 2010 Aug; 2(8):1449-60. PubMed ID: 21083345
[TBL] [Abstract][Full Text] [Related]
23. Application of a liquid extraction based sealing surface sampling probe for mass spectrometric analysis of dried blood spots and mouse whole-body thin tissue sections.
Van Berkel GJ; Kertesz V
Anal Chem; 2009 Nov; 81(21):9146-52. PubMed ID: 19817477
[TBL] [Abstract][Full Text] [Related]
24. Direct analysis in real time coupled with dried spot sampling for bioanalysis in a drug-discovery setting.
Crawford E; Gordon J; Wu JT; Musselman B; Liu R; Yu S
Bioanalysis; 2011 Jun; 3(11):1217-26. PubMed ID: 21649498
[TBL] [Abstract][Full Text] [Related]
25. Validation of individual quantitative methods for determination of cytochrome P450 probe substrates in human dried blood spots with HPLC-MS/MS.
Lad R
Bioanalysis; 2010 Nov; 2(11):1849-61. PubMed ID: 21083493
[TBL] [Abstract][Full Text] [Related]
26. Dried blood spot sampling: practical considerations and recommendation for use with preclinical studies.
Burnett JE
Bioanalysis; 2011 May; 3(10):1099-107. PubMed ID: 21585305
[TBL] [Abstract][Full Text] [Related]
27. A powerful couple in the future of clinical biochemistry: in situ analysis of dried blood spots by ambient mass spectrometry.
Corso G; D'Apolito O; Gelzo M; Paglia G; Dello Russo A
Bioanalysis; 2010 Nov; 2(11):1883-91. PubMed ID: 21083496
[TBL] [Abstract][Full Text] [Related]
28. Method of applying internal standard to dried matrix spot samples for use in quantitative bioanalysis.
Abu-Rabie P; Denniff P; Spooner N; Brynjolffssen J; Galluzzo P; Sanders G
Anal Chem; 2011 Nov; 83(22):8779-86. PubMed ID: 21972889
[TBL] [Abstract][Full Text] [Related]
29. Determination of drug concentrations using dried blood spots: investigation of blood sampling and collection techniques in Crl:CD(SD) rats.
Stokes AH; Moose TA; Parry SP; Barfield M; Lovatt CA; Dopson WJ; Melich D; Overvold CR; Gade SD; Spooner N
Lab Anim; 2011 Apr; 45(2):109-13. PubMed ID: 21444352
[TBL] [Abstract][Full Text] [Related]
30. Utility of dried blood spot sampling and storage for increased stability of photosensitive compounds.
Bowen CL; Hemberger MD; Kehler JR; Evans CA
Bioanalysis; 2010 Nov; 2(11):1823-8. PubMed ID: 21083490
[TBL] [Abstract][Full Text] [Related]
31. Dried matrix spot direct analysis: evaluating the robustness of a direct elution technique for use in quantitative bioanalysis.
Abu-Rabie P; Spooner N
Bioanalysis; 2011 Dec; 3(24):2769-81. PubMed ID: 22185277
[TBL] [Abstract][Full Text] [Related]
32. Utilization of dried blood spots within drug discovery: modification of a standard DiLab(®) AccuSampler(®) to facilitate automatic dried blood spot sampling.
Clark GT; Giddens G; Burrows L; Strand C
Lab Anim; 2011 Apr; 45(2):124-6. PubMed ID: 21355022
[TBL] [Abstract][Full Text] [Related]
33. Dried matrix on paper disks: the next generation DBS microsampling technique for managing the hematocrit effect in DBS analysis.
Meesters RJ; Zhang J; van Huizen NA; Hooff GP; Gruters RA; Luider TM
Bioanalysis; 2012 Aug; 4(16):2027-35. PubMed ID: 22946918
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetic considerations as to when to use dried blood spot sampling.
Emmons G; Rowland M
Bioanalysis; 2010 Nov; 2(11):1791-6. PubMed ID: 21083484
[TBL] [Abstract][Full Text] [Related]
35. Application of DBS for quantitative assessment of the peptide Exendin-4; comparison of plasma and DBS method by UHPLC-MS/MS.
Kehler JR; Bowen CL; Boram SL; Evans CA
Bioanalysis; 2010 Aug; 2(8):1461-8. PubMed ID: 21083346
[TBL] [Abstract][Full Text] [Related]
36. [Interference in the creatine kinase assay: the "wave" phenomenon].
Cohen S
Ann Biol Clin (Paris); 2003; 61(3):328-31. PubMed ID: 12805011
[No Abstract] [Full Text] [Related]
37. Increasing efficiency for dried blood spot analysis: prospects for automation and simplified sample analysis.
Wong P; Pham R; Bruenner BA; James CA
Bioanalysis; 2010 Nov; 2(11):1787-9. PubMed ID: 21083483
[No Abstract] [Full Text] [Related]
38. Determination of mycophenolic acid and its phenyl glucuronide in human plasma, ultrafiltrate, blood, DBS and dried plasma spots.
Heinig K; Bucheli F; Hartenbach R; Gajate-Perez A
Bioanalysis; 2010 Aug; 2(8):1423-35. PubMed ID: 21083343
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of factors influencing precision in the analysis of samples taken from blood spots on filter paper.
O'Broin SD; Kelleher BP; Gunter E
Clin Lab Haematol; 1995 Jun; 17(2):185-8. PubMed ID: 8536424
[TBL] [Abstract][Full Text] [Related]
40. Managing the effect of hematocrit on DBS analysis in a regulated environment.
Fan L; Lee JA
Bioanalysis; 2012 Feb; 4(4):345-7. PubMed ID: 22394133
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
